首页> 外国专利> Antidepressant minaprine or deriv. prepn. - from 3-methoxy-6-chloro-pyridazine via new 3-methoxy-6-(hetero)aryl-pyridazine deriv.

Antidepressant minaprine or deriv. prepn. - from 3-methoxy-6-chloro-pyridazine via new 3-methoxy-6-(hetero)aryl-pyridazine deriv.

机译:抗抑郁米帕林或衍生物。准备-从3-甲氧基-6-氯哒嗪经新的3-甲氧基-6-(杂)芳基-哒嗪衍生物衍生。

摘要

3-Methoxy-6-(hetero)aryl-pyrazine derivs. of formula (I) are new: R1 = H or a gp. E selected from halogen (pref. Br or I), 1-8C (pref. 1-4C) alkyl, SO3H, SO2H, SH, SRa, CH2OH, CHRaOH, CraRb-OH (or their ethers), COOH, COORa, CORa, CHO, CO (sic), CONH2, N3, NH2, NHRa, NRaRb, B(ORa)2, B(OH)2, SnRa, SiRa (sic) or As(Ra)2; Ra, Rb = 1-8C (pref. 1-4C) alkyl; R2 = opt. substd. aromatic or heteroaromatic gp. Prepn. of minaprine and its derivs. of formula (VI) comprises: (i) reacting 3-methoxy-6-chloropyridazine of formula (II) with a (hetero)aryl boronic acid deriv. of formula R2-B(OH)2 (III) to give (I; R1=H); (ii) opt. converting (I; R1=H) into (I; R=E) by reacting with a metallising agent followed by an electrophile and opt. further converting the substit. introduced (e.g. by hydrolysis or redn.; (iii) reacting (I) with halogenated acid to give a pyridazinone of formula (V); (iv) reacting (V) with a chlorinating agent to give a 3-chloropyridazine deriv. of formula (VII); and (v) reacting (VII) with 4-(2-aminoethyl)-morpholine (VIII): Also claimed are the prepn. of (I) by step (i) and opt. step (ii); and the use of (I) for prepn. of (V). R2 = 6-10C aromatic gp. (e.g. phenyl or naphthyl), 5- or 6- membered N-contg. heterocycle (e.g. imidazole, pyridine, pyrimidine or pyridazine), O-contg. heterocycle (e.g. oxazole), O- and N-contg. heterocycle (e.g. oxadiazole) or S-contg. heterocycle (e.g. thiazole); R2 gps. are all opt. substd. by one or more of halogen, OH, ORa, alkyl, alkenyl or alkynyl (pref. with 1-8C, esp. 1-4C), COOH, COORa, CORa, CH2OH, CHRaOH, CRaRbOH (or their ethers), CHO, CONH2, NH2, NHRa, NRaRb, S, SH, SRa, NO2 or functional gps. such as amine, ketone, sulphydryl or amide. In step (ii) for the prepn. of (I), metallation reaction may be followed by transmetallation to replace the metal introduced by an orgaometallic gp. USE/ADVANTAGE - Minaprine, i.e. (VI; R1 = Me; R2 = Ph), is an antidepressant. Minaprine can be prepd. easily and rapidly from a starting material readily obtainable from maleic anhydride. A wide range of substd. minaprine derivs. can be prepd. Overall yield is ca. 35% starting from dichloropyridazine (sic). In an example, a degassed mixt. of 20 ml toluene, 1 ml 2 M aq. Na2CO3 and 0.55 ml EtOH was treated successively at room temp. with 0.145g (II), 0.187g phenylboronic acid and 0.042g Pd(PPh3)4 (catalyst), heated at reflux until reaction was complete by TLC (ca. 12 hrs.) and evapd. The prod. was worked up and purified by silica gel chromatography to give 0.14g (75%) of 3-methoxy-6-phenylpyridazine, m.pt. 116 deg.C. The prod. was converted successively into 3-methoxy-4-phenyl-pyridazine (by reaction with -Buli in THF then with MeI; 81% yield), 4-methyl-6-phenyl-3(2H)-pyridazinone (by reaction with aq. HI; 96% yield) and minaprine (by reaction with POCl3 then (VIII); no detail given).
机译:3-甲氧基-6-(杂)芳基-吡嗪衍生物。式(I)的化学式是新的:R 1 = H或gp。 E选自卤素(优选Br或I),1-8C(优选1-4C)烷基,SO3H,SO2H,SH,SRa,CH2OH,CHRaOH,CraRb-OH(或其醚),COOH,COORa,CORa ,CHO,CO(sic),CONH2,N3,NH2,NHRa,NRaRb,B(ORa)2,B(OH)2,SnRa,SiRa(sic)或As(Ra)2; Ra,Rb = 1-8C(优选1-4C)烷基; R2 =最佳。取代芳香族或杂芳香族准备米那芬及其衍生物。式(VI)的通式(VI)包括:(i)使式(II)的3-甲氧基-6-氯哒嗪与(杂)芳基硼酸衍生物反应。式R2-B(OH)2(III)的化合物,得到(I; R1 = H); (ii)选择。通过与金属化剂反应,然后与亲电试剂反应,将(I; R1 = H)转化为(I; R = E)。进一步转换替代。引入(例如通过水解或还原);(iii)使(I)与卤代酸反应以得到式(V)的哒嗪酮;(iv)使(V)与氯化剂反应以得到式3-氯哒嗪衍生物(VII);和(v)使(VII)与4-(2-氨基乙基)-吗啉(VIII)反应:还要求保护步骤(i)和步骤(ii)的(I)制备;和R2 = 6-10C芳香族基(例如苯基或萘基),5或6元N-含杂环(例如咪唑,吡啶,嘧啶或哒嗪)的用途,O-含杂环(例如恶唑),O-和N-含杂环(例如恶二唑)或S-含杂环(例如噻唑); R2 gps。全都被一个或多个卤素取代; OH,ORa,烷基,烯基或炔基(优选1-8C,尤其是1-4C),COOH,COORa,CORa,CH2OH,CHRaOH,CRaRbOH(或其醚),CHO,CONH2,NH2,NHRa,NRaRb ,S,SH,SRa,NO2或功能性gps。,例如胺,酮,巯基或酰胺。在制备(I)的步骤(ii)中,金属化反应离子之后可以进行金属置换,以取代由有机金属gp引入的金属。用途/优点-米那芬,即(VI; R1 = Me; R2 = Ph)是抗抑郁药。可以制备米那芬。容易和迅速地从容易得自马来酸酐的原料中得到。种类繁多。米那芬衍生。可以准备。总产量约为。 35%从二氯哒嗪开始(原文如此)。在一个示例中,为脱气混合物。 20毫升甲苯,1毫升2 M水溶液在室温下依次处理Na2CO3和0.55 ml EtOH。将其与0.145g(II),0.187g苯基硼酸和0.042g Pd(PPh 3)4(催化剂)一起加热回流,直至通过TLC(约12小时)反应完全并蒸发。产品。进行后处理并通过硅胶色谱法纯化,得到0.14g(75%)的3-甲氧基-6-苯基哒嗪,m.pt。 116℃产品。将其依次转化为3-甲氧基-4-苯基-哒嗪(通过与-Buli在THF中反应,然后与MeI; 81%收率),4-甲基-6-苯基-3(2H)-哒嗪酮(通过与NaHCO 3水溶液反应)。 HI; 96%收率)和米那芬(通过与POCl 3然后(VIII)反应;未给出细节)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号